Paroxysmal movement disorders in severe myoclonic epilepsy in infancy

Yoko Ohtsuka, Iori Ohmori, Tatsuya Ogino, Mamoru Oouchida, Kenji Shimizu, Eiji Oka

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

We report on the electroclinical findings and the results of a molecular genetic study of a patient with typical severe myoclonic epilepsy in infancy (TSME) and three with borderline SME (BSME) who showed paroxysmal movement disorders, such as choreoathetosis, dystonia and ballismus, during their clinical course. BSME was defined as a clinical entity that shares common characteristics with TSME but lacks myoclonic seizures associated with ictal EEG changes. When the paroxysmal movement disorders were first observed, all the patients in this study were being treated with polytherapy including phenytoin (PHT), and these abnormal movements disappeared when PHT was discontinued or reduced. However, on other occasions, two of our cases also showed the same abnormal movements even when not being treated with PHT. One patient with TSME and two of the three patients with BSME had SCN1A gene mutations that lead to truncation of the associated protein. We conclude that paroxysmal movement disorders seen in SME patients were closely related to their AED therapy, especially the use of PHT. It is thought that patients with both TSME and BSME have some predisposition toward paroxysmal movement disorders, and that this predisposition is partly related to sodium channel dysfunction, although some other factors might influence the occurrence of this phenomenon.

Original languageEnglish
Pages (from-to)401-405
Number of pages5
JournalBrain and Development
Volume25
Issue number6
DOIs
Publication statusPublished - Sep 2003

Fingerprint

Myoclonic Epilepsy
Movement Disorders
Phenytoin
Dyskinesias
Dystonia
Sodium Channels
Molecular Biology
Electroencephalography
Seizures
Stroke
Mutation
Genes

Keywords

  • Antiepileptic drug
  • Paroxysmal movement disorder
  • Phenytoin
  • SCN1A mutation
  • Severe myoclonic epilepsy in infancy
  • Sodium channel

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health
  • Neurology

Cite this

Paroxysmal movement disorders in severe myoclonic epilepsy in infancy. / Ohtsuka, Yoko; Ohmori, Iori; Ogino, Tatsuya; Oouchida, Mamoru; Shimizu, Kenji; Oka, Eiji.

In: Brain and Development, Vol. 25, No. 6, 09.2003, p. 401-405.

Research output: Contribution to journalArticle

Ohtsuka, Yoko ; Ohmori, Iori ; Ogino, Tatsuya ; Oouchida, Mamoru ; Shimizu, Kenji ; Oka, Eiji. / Paroxysmal movement disorders in severe myoclonic epilepsy in infancy. In: Brain and Development. 2003 ; Vol. 25, No. 6. pp. 401-405.
@article{ac8aadb992574c0a86291c0edd69e330,
title = "Paroxysmal movement disorders in severe myoclonic epilepsy in infancy",
abstract = "We report on the electroclinical findings and the results of a molecular genetic study of a patient with typical severe myoclonic epilepsy in infancy (TSME) and three with borderline SME (BSME) who showed paroxysmal movement disorders, such as choreoathetosis, dystonia and ballismus, during their clinical course. BSME was defined as a clinical entity that shares common characteristics with TSME but lacks myoclonic seizures associated with ictal EEG changes. When the paroxysmal movement disorders were first observed, all the patients in this study were being treated with polytherapy including phenytoin (PHT), and these abnormal movements disappeared when PHT was discontinued or reduced. However, on other occasions, two of our cases also showed the same abnormal movements even when not being treated with PHT. One patient with TSME and two of the three patients with BSME had SCN1A gene mutations that lead to truncation of the associated protein. We conclude that paroxysmal movement disorders seen in SME patients were closely related to their AED therapy, especially the use of PHT. It is thought that patients with both TSME and BSME have some predisposition toward paroxysmal movement disorders, and that this predisposition is partly related to sodium channel dysfunction, although some other factors might influence the occurrence of this phenomenon.",
keywords = "Antiepileptic drug, Paroxysmal movement disorder, Phenytoin, SCN1A mutation, Severe myoclonic epilepsy in infancy, Sodium channel",
author = "Yoko Ohtsuka and Iori Ohmori and Tatsuya Ogino and Mamoru Oouchida and Kenji Shimizu and Eiji Oka",
year = "2003",
month = "9",
doi = "10.1016/S0387-7604(03)00025-1",
language = "English",
volume = "25",
pages = "401--405",
journal = "Brain and Development",
issn = "0387-7604",
publisher = "Elsevier",
number = "6",

}

TY - JOUR

T1 - Paroxysmal movement disorders in severe myoclonic epilepsy in infancy

AU - Ohtsuka, Yoko

AU - Ohmori, Iori

AU - Ogino, Tatsuya

AU - Oouchida, Mamoru

AU - Shimizu, Kenji

AU - Oka, Eiji

PY - 2003/9

Y1 - 2003/9

N2 - We report on the electroclinical findings and the results of a molecular genetic study of a patient with typical severe myoclonic epilepsy in infancy (TSME) and three with borderline SME (BSME) who showed paroxysmal movement disorders, such as choreoathetosis, dystonia and ballismus, during their clinical course. BSME was defined as a clinical entity that shares common characteristics with TSME but lacks myoclonic seizures associated with ictal EEG changes. When the paroxysmal movement disorders were first observed, all the patients in this study were being treated with polytherapy including phenytoin (PHT), and these abnormal movements disappeared when PHT was discontinued or reduced. However, on other occasions, two of our cases also showed the same abnormal movements even when not being treated with PHT. One patient with TSME and two of the three patients with BSME had SCN1A gene mutations that lead to truncation of the associated protein. We conclude that paroxysmal movement disorders seen in SME patients were closely related to their AED therapy, especially the use of PHT. It is thought that patients with both TSME and BSME have some predisposition toward paroxysmal movement disorders, and that this predisposition is partly related to sodium channel dysfunction, although some other factors might influence the occurrence of this phenomenon.

AB - We report on the electroclinical findings and the results of a molecular genetic study of a patient with typical severe myoclonic epilepsy in infancy (TSME) and three with borderline SME (BSME) who showed paroxysmal movement disorders, such as choreoathetosis, dystonia and ballismus, during their clinical course. BSME was defined as a clinical entity that shares common characteristics with TSME but lacks myoclonic seizures associated with ictal EEG changes. When the paroxysmal movement disorders were first observed, all the patients in this study were being treated with polytherapy including phenytoin (PHT), and these abnormal movements disappeared when PHT was discontinued or reduced. However, on other occasions, two of our cases also showed the same abnormal movements even when not being treated with PHT. One patient with TSME and two of the three patients with BSME had SCN1A gene mutations that lead to truncation of the associated protein. We conclude that paroxysmal movement disorders seen in SME patients were closely related to their AED therapy, especially the use of PHT. It is thought that patients with both TSME and BSME have some predisposition toward paroxysmal movement disorders, and that this predisposition is partly related to sodium channel dysfunction, although some other factors might influence the occurrence of this phenomenon.

KW - Antiepileptic drug

KW - Paroxysmal movement disorder

KW - Phenytoin

KW - SCN1A mutation

KW - Severe myoclonic epilepsy in infancy

KW - Sodium channel

UR - http://www.scopus.com/inward/record.url?scp=0043168129&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0043168129&partnerID=8YFLogxK

U2 - 10.1016/S0387-7604(03)00025-1

DO - 10.1016/S0387-7604(03)00025-1

M3 - Article

VL - 25

SP - 401

EP - 405

JO - Brain and Development

JF - Brain and Development

SN - 0387-7604

IS - 6

ER -